Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.
Sheppard M, Bronstein MD, Freda P, Serri O, De Marinis L, Naves L, Rozhinskaya L, Hermosillo Reséndiz K, Ruffin M, Chen Y, Colao A. Sheppard M, et al. Among authors: naves l. Pituitary. 2015 Jun;18(3):395-6. doi: 10.1007/s11102-014-0628-z. Pituitary. 2015. PMID: 25566750 Free PMC article. No abstract available.
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.
Sheppard M, Bronstein MD, Freda P, Serri O, De Marinis L, Naves L, Rozhinskaya L, Hermosillo Reséndiz K, Ruffin M, Chen Y, Colao A. Sheppard M, et al. Among authors: naves l. Pituitary. 2015 Jun;18(3):385-94. doi: 10.1007/s11102-014-0585-6. Pituitary. 2015. PMID: 25103549 Free PMC article. Clinical Trial.
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
Medical combination therapies in Cushing's disease.
Vilar L, Naves LA, Machado MC, Bronstein MD. Vilar L, et al. Among authors: naves la. Pituitary. 2015 Apr;18(2):253-62. doi: 10.1007/s11102-015-0641-x. Pituitary. 2015. PMID: 25647330
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.
Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC, Guerrero DP, Barrera CA, Franco HI, Ribeiro-Oliveira A Jr, Vilar L, Jallad RS, Duarte FG, Gadelha M, Boguszewski CL, Abucham J, Naves LA, Musolino NR, de Faria ME, Rossato C, Bronstein MD. Abreu A, et al. Among authors: naves la. Pituitary. 2016 Aug;19(4):448-57. doi: 10.1007/s11102-016-0725-2. Pituitary. 2016. PMID: 27279011 Free PMC article. Review.
Management of prolactinomas in Brazil: an electronic survey.
Vilar L, Naves LA, Casulari LA, Azevedo MF, Albuquerque JL, Serfaty FM, Pinho Barbosa FR, de Oliveira AR Jr, Montenegro RM, Montenegro RM Jr, Ramos AJ, Dos Santos Faria M, Musolino NR, Gadelha MR, Boguszewski CL, Bronstein MD. Vilar L, et al. Among authors: naves la. Pituitary. 2010 Sep;13(3):199-206. doi: 10.1007/s11102-010-0217-8. Pituitary. 2010. PMID: 20107911
A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Vieira L Neto, Boguszewski CL, Araújo LA, Bronstein MD, Miranda PA, Musolino NR, Naves LA, Vilar L, Ribeiro-Oliveira A Júnior, Gadelha MR. Vieira L Neto, et al. Among authors: naves la. Arch Endocrinol Metab. 2016 Aug;60(4):374-90. doi: 10.1590/2359-3997000000179. Arch Endocrinol Metab. 2016. PMID: 27533614 Free PMC article. Review.
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A. Rostomyan L, et al. Among authors: naves la. Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17. Endocr Relat Cancer. 2015. PMID: 26187128 Free PMC article.
Brazilian multicenter study on pegvisomant treatment in acromegaly.
Boguszewski CL, Huayllas MKP, Vilar L, Naves LA, Ribeiro-Oliveira Junior A, Soares BS, Czepielewski MA, Abucham J, Correa-Silva SR, Bronstein MD, Jallad RS, Duarte FG, Musolino NR, Kasuki L, Gadelha MR. Boguszewski CL, et al. Among authors: naves la. Arch Endocrinol Metab. 2019 Jul 29;63(4):328-336. doi: 10.20945/2359-3997000000159. Arch Endocrinol Metab. 2019. PMID: 31365632 Free PMC article.
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
Vieira Neto L, Abucham J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M, Jallad RS, Musolino NR, Naves LA, Ribeiro-Oliveira Júnior A, Vilar L, Faria Mdos S, Gadelha MR. Vieira Neto L, et al. Among authors: naves la. Arq Bras Endocrinol Metabol. 2011 Mar;55(2):91-105. doi: 10.1590/S0004-27302011000200001. Arq Bras Endocrinol Metabol. 2011. PMID: 21584426 Review. Portuguese.
206 results